Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector

Published:2010-05-20 Issue:10 Volume:17 Page:1244-1252
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Becker P S,Taylor J A,Trobridge G D,Zhao X,Beard B C,Chien S,Adair J,Kohn D B,Wagner J E,Shimamura A,Kiem H-P

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt201062.pdf

Reference27 articles.

1. Bagby GC, Alter BP . Fanconi anemia (Review). Semin Hematol 2006; 43: 147–156.

2. Taniguchi T, D'Andrea AD . Molecular pathogenesis of Fanconi anemia: recent progress (Review). Blood 2006; 107: 4223–4233.

3. Wang W . Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins (Review). Nat Rev Genet 2007; 8: 735–748.

4. Liu JM, Kim S, Read EJ, Futaki M, Dokal I, Carter CS et al. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC). Hum Gene Ther 1999; 10: 2337–2346.

5. Yamada K, Olsen JC, Patel M, Rao KW, Walsh CE . Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector. Mol Ther 2001; 3: 485–490.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous targeting of Tim3 and A2a receptors modulates MSLN-CAR T cell antitumor function in a human cervical tumor xenograft model;Frontiers in Immunology;2024-05-24

2. A systematic review investigating advances in gene therapy for Fanconi anemia over the last three decades;Frontiers in Hematology;2023-08-03

3. The inhibitory receptors PD1, Tim3, and A2aR are highly expressed during mesoCAR T cell manufacturing in advanced human epithelial ovarian cancer;Cancer Cell International;2023-05-27

4. Gene therapy and editing in the treatment of hereditary blood disorders: Medical and ethical aspects;Clinical Ethics;2021-11-06

5. Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4;Frontiers in Immunology;2020-08-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3